AMS Women’s Health Psychiatry and Infectious Diseases 2024

AMS Women’s Health Psychiatry and Infectious Diseases 2024

+ Target Audience: internists, family physicians, hospitalists, infectious diseases physicians + Information:

Women’s Health/Psychiatry and Infectious Diseases is organized by American Medical Seminars (AMS), Inc. and will be held from Jun 24 – 27, 2024 at Embassy Suites by Hilton Sarasota, Sarasota, Florida, United States of America.

The American Medical Seminars – Women’s Health, Psychiatry, and Infectious Diseases 2024 program is best for internists, family physicians, hospitalists, and advanced practice providers who want a clinically focused update on common problems in women’s health, psychiatric care, and infectious disease management. It is designed to strengthen everyday diagnostic and therapeutic decision‑making in both inpatient and outpatient settings.

 Who Should Attend

• Hospitalists & internists managing women’s health and infectious disease cases in hospital practice.
• Family physicians & general practitioners encountering psychiatric and women’s health issues in primary care.
• Residents & fellows in internal medicine, family medicine, or psychiatry seeking structured review.
• Advanced practice providers (NPs, PAs) working in hospital or outpatient clinics.
• Allied health professionals interested in broadening their knowledge of women’s health and infectious disease.

What You’ll Learn

• Women’s health updates: gynecologic conditions, preventive care, and management of common female health problems.
• Psychiatry essentials: depression, anxiety, bipolar disorder, and psychiatric emergencies in hospital and outpatient settings.
• Infectious disease management: skin/soft tissue infections, respiratory infections, and emerging pathogens.
• Case‑based instruction: practical examples for real‑world application.
• Evidence‑based protocols: diagnostic strategies and treatment updates aligned with current guidelines.

  + Topics: Day 1 Chronic Venous Insufficiency Upon completion of this session, the participant should be able to:

• Apply appropriate diagnostic and therapeutic approaches in the management of patients across the entire spectrum of venous disease

Pelvic Phlebology Upon completion of this session, the participant should be able to:

• Identify causes and sequelae of CVI unique to the pelvic anatomy in female patients

Medical evaluation of the psychiatric patient Attendees of this presentation should be able to:

• Evaluate the medical clearance process
• Utilize protocols for the evaluation of psychiatric patients
• Consider the role of verbal de-escalation in the treatment of psychiatric patients
• Determine the appropriate treatment for psychiatric patients in the emergency setting

Depression Attendees of this presentation should be able to:

• Review signs and symptoms of depression
• Assess the presentation of depression across the lifespan
• Consider pharmacological and non-pharmacological treatment options for depression

Substance Use Disorders Attendees of this presentation should be able to:

• Evaluate the risk factors leading to substance abuse and addiction
• Utilize several screening tools for substance abuse and addiction
• Review the medical and psychiatric consequences and comorbidities of substance abuse
• Utilize biological and psychosocial treatments for substance abuse

Day 2 Dealing with Difficult Patients Attendees of this presentation should be able to:

• Describe why some patients and family members might be difficult to deal with difficult people
• Recognize and respond to difficult individuals identify various types of difficult people
• Implement techniques to deal with difficult patients and family members
• Evaluate how medical and psychiatric illness affects difficult people

Anxiety Disorders Attendees of this presentation should be able to:

• Review the impact of anxiety disorders
• Compare the diagnostic criteria for panic disorder, agoraphobia, general anxiety disorders and social anxiety disorder.
• Evaluate treatment options for anxiety disorders

Provider Wellness Attendees of this presentation should be able to:

• Identify and define stress and how it affects us
• Differentiate, diagnose and treat PTSD and Burnout
• Understand and deal with the affects of COVID on physician wellness

Pelvic Pain and Endometriosis Upon completion of this session, the participant should be able to:

• Analyze pelvic pain in the clinical setting of endometriosis and differentiate between dysmenorrhea, non-menstrual pelvic pain and pain with intercourse
• Discuss non-endometriotic causes of pelvic pain
• Discuss the potential value of micro-RNA in diagnosis and treatment

Polycystic Ovarian Syndrome Upon completion of this session, the participant should be able to:

• Develop a cost-effective thorough plan for assessing PCOS and its sequelae in patients who do and do not want to conceive
• Discuss diagnostic criteria for PCOS and different phenotypes

Day 3 Abnormal Uterine Bleeding Upon completion of this session, the participant should be able to:

• Identify and classify the etiology of abnormal uterine bleeding
• Define the correct terminology used in patients with abnormal uterine bleeding
• Discussed treatments in the management of patients with abnormal uterine bleeding

Office Urogynecology Upon completion of this session, the participant should be able to:

• Appreciate the independent subspecialty of urogynecology as distinguished from general gynecology, urology, and colon-rectal surgery.
• Prepare a patient for an appointment with a urogynecologist.
• Describe various surgical (including pessaries) and medical treatments for urine incontinence, recurrent UTIs and obstetrical anal sphincter injuries.

Vaginitis Revisited Upon completion of this session, the participant should be able to:

• Identify routine as well as challenging causes of vulvar symptoms of burning, itching or pain
• Expand upon vaginitis related to infection, estrogen deprivation and dermatological skin changes

TB and Non-TB Mycobacterial infection Update 2024 Attendees of this presentation will be able to:

• Stratify their suspicion for tuberculosis vs. Non-TB mycoacteria based on the patient’s residence in or origin from a high TB-incidence country.
• Evaluate the trends in frequency of TB vs. Non-TB mycobacteria.
• Compare and contrast the environmental reservoir of non-TB mycobacteria.

Skin & Soft Tissue Infections Attendees of this presentation will be able to:

• Accurately distinguish between cellulitis and venous stasis dermatitis.
• Determine how the microbiology of diabetic foot ulcer differs from that of cellulitis.

Day 4 Infectious Complications of Opiate Addiction Epidemic Attendees of this presentation will be able to:

• Evaluate the trends in opioid use, overdoses and deaths in the US and assess the reasons for the opioid epidemic in our country.
• Develop strategies to accurately identify injection site abscess
• Recognize the appearance of septic emboli to the lungs in IV drug users

Covid-19, Lessons Learned and Long Covid Attendees of this presentation will be able to:

• Identify key features of Covid-19 pneumonitis such as ground-glass infiltrates and lymphopenia.
• Evaluate the roles of key treatments such as remdesivir, dexamethasone, and monoclonal antibody therapies for Covid-19.
• Analyze the differences between Covid-19 vaccines available in the U.S.
• Develop self-care strategies to help care providers cope with the stress of a Covid-19 outbreak in their community.

Osteoporosis Understood  Upon completion of this session, the participant should be able to:

• Identify demographic risk factors for osteoporosis, pathophysiology, diagnosis and medical treatment

Anemia in Pregnancy Upon completion of this session, the participant should be able to:

• Define anemia in pregnancy and differentiate between physiological, acquired and inherited disease
• Discuss the diagnostic workup of anemia and oral and parenteral treatments including blood transfusion and associated sequelae.

HPV and Cervical Cytology Upon completion of this session, the participant should be able to:

• Review HPV and understand the different serotypes
• Differentiate Metaplasia from Dysplasia
• Appreciate the histopathology of cervical dysplasia
• Understand the role of the Pap test as a screening tool and colposcopy as a diagnostic study